Method for manufacturing protein drug
The present invention provides a method for manufacturing a virus-free protein drug, comprising (a) a filtration step of filtering a virus-containing protein solution through a small-pore size virus removal membrane to obtain a virus-free protein solution, the filtration step (a) comprising (q) a low-pressure filtration step of filtering the solution through the small-pore size virus removal membrane at a filtration pressure of 0.30 kgf/cm 2 or lower to obtain the virus-free protein solution, wherein the solution prior to filtration in the low-pressure filtration step (q) has a pH (X) and a salt ionic strength (Y (mM)) that satisfy the following equations 1 and 5: 0≦Y≦150X−590 (Equation 1) and 3.5≦X≦8.0 (Equation 5) or the following equations 4 and 5: Y=0 (Equation 4) and 3.5≦X≦8.0 (Equation 5).
1. A method for manufacturing a virus-free protein drug, comprising the following step (a):
(a) filtering a virus containing protein solution through a small-pore size virus removal membrane to obtain a virus-free protein solution,
comprising
a low-pressure filtration step (q) of filtering a solution through the small-pore size virus removal membrane at a filtration pressure of 0.30 kgf/cm 2 or lower,
wherein the solution prior to filtration in the low-pressure filtration step (q) has a pH (X) and a salt ionic strength (Y (mM)) that satisfy the following equations 1 and 5:
0 ≦Y ≦150 X −590 (Equation 1)
3.5≦X≦8.0 (Equation 5)
or the following equations 4 and 5:
Y=0 (Equation 4)
3.5≦X≦8.0, (Equation 5)
and
a high-pressure filtration step (p) of filtering the virus-containing protein solution through the small-pore size virus removal membrane at a filtration pressure exceeding 0.30 kgf/cm 2 , which is performed prior to the low-pressure filtration step (q),
wherein the low-pressure filtration step (q) is a post-wash step or a stop and start step, and
wherein pressurization is suspended during the filtration and then restarted in the stop and start step.
2. The method according to claim 1 , wherein the solution prior to filtration in the step (q) is the virus-containing protein solution, and
wherein 50% or more of the whole virus-containing protein solution to be filtered in the filtration step (a) is filtered in the low-pressure filtration step (q).
3. The method according to claim 1 , wherein the filtration step (a) is a step of filtering the virus-containing protein solution through the small-pore size virus removal membrane at a filtration pressure of 0.30 kgf/cm 2 or lower to obtain the virus-free protein solution, wherein the solution prior to filtration in the filtration step (a) has a pH (X) and a salt ionic strength (Y (mM)) that satisfy the following equations 1 and 5:
0 ≦Y ≦150 X −590 (Equation 1)
3.5≦X≦8.0 (Equation 5)
or the following equations 4 and 5:
Y=0 (Equation 4)
3.5≦X≦8.0. (Equation 5)
4. The method according to claim 1 , wherein the solution prior to filtration in the low-pressure filtration step (q) is a buffer solution for washing.
5. The method according to claim 1 , wherein the filtration solution in the low-pressure filtration step (q) has a pH (X) and a salt ionic strength (Y (mM)) that satisfy the following equations 2 and 5:
0 Y ≦50 X −200 (Equation 2)
3.5≦X≦8.0 (Equation 5)
or the following equations 4 and 5:
Y=0 (Equation 4)
3.5≦X≦8.0. (Equation 5)
6. The method according to claim 1 , wherein the solution prior to filtration in the low-pressure filtration step (q) has a pH (X) and a salt ionic strength (Y (mM)) that satisfy the following equations 3 and 5:
Y ≦50 ≦X −250 (Equation 3)
3.5≦X≦8.0 (Equation 5)
or the following equations 4 and 5:
Y=0 (Equation 4)
3.5≦X≦8.0. (Equation 5)
7. The method according to claim 1 , wherein the low-pressure filtration step (q) is a step of filtering the solution through the small-pore size virus removal membrane at a filtration pressure of 0.20 kgf/cm 2 or lower to obtain the virus-free protein solution.
8. The method according to claim 1 , wherein a log reduction value (LRV) calculated according to the following equation 6 is 4 or higher:
LRV=log 10 ( C 0 / C F ) (Equation 6)
wherein C 0 represents the virus concentration of the virus-containing protein solution before the filtration step (a), and C F represents the virus concentration of the virus-free protein solution after the filtration.
9. The method according to claim 4 , wherein a log reduction value (LRV) calculated according to the following equation 6 is 4 or higher:
LRV=log 10 ( C 0 / C F ) (Equation 6)
wherein C 0 represents the virus concentration of the virus-containing protein solution before the filtration step (a), and C F represents the virus concentration of the virus-free protein solution after the filtration, and LRV' calculated according to the following equation 7 is 4 or higher:
LRV=log 10 ( C 0 / C w ) (Equation 7)
wherein C 0 represents the virus concentration of the virus-containing protein solution before the filtration step (a), and C w represents the virus concentration of the filtrate of the buffer solution for washing after the filtration step (a).
10. The method according to claim 1 , wherein the material of the small-pore size virus removal membrane is cellulose or a hydrophilized synthetic polymer.
11. The method according to claim 1 , wherein the material of the small-pore size virus removal membrane is a hydrophilized synthetic polymer, and wherein the synthetic polymer is selected from the group consisting of polyvinylidene fluoride, polyether sulfone, polysulfone, and polyethylene.
12. The method according to claim 1 , wherein the form of the small-pore size virus removal membrane is a flat membrane or a hollow fiber membrane.
13. The method according to claim 1 , wherein the virus-containing protein solution has a protein concentration of 1 mg/mL to 100 mg/mL.
14. The method according to claim 1 , wherein the virus-containing protein solution comprises one or more protein(s) selected from the group consisting of monoclonal antibodies, recombinant blood coagulation factor, interferon, hormones, enzymes, immunoglobulin, albumin, blood coagulation factor VIII, blood coagulation factor IX, fibrinogen, and antithrombin III.
15. The method according to claim 1 , wherein the virus-containing protein solution comprises an antibody as the protein.
16. The method according to claim 1 , wherein the virus-containing protein solution comprises blood coagulation factor VIII or fibrinogen as the protein.
17. The method according to claim 1 , wherein the virus-containing protein solution comprises one or more virus(es) selected from the group consisting of human parvovirus B19 (B19), minute virus of mice (MVM), porcine parvovirus (PPV), bovine parvovirus (BPV), canine parvovirus (CPV), poliovirus (Polio), circovirus, hepatitis A virus (HAV), and hepatitis E virus (HEV).
18. The method according to claim 1 , wherein the virus-containing protein solution comprises a virus of 32 nm or smaller in diameter having no envelope.
19. The method according to claim 1 , wherein the virus-containing protein solution comprises one or more component(s) selected from the group consisting of an inorganic salt, a buffer solution component, a surfactant, and a saccharide.
20. A method for manufacturing a virus-free protein drug, comprising the following step (a):
(a) filtering a virus containing protein solution through a small-pore size virus removal membrane to obtain a virus-free protein solution,
comprising
a low-pressure filtration step (q) of filtering a solution through the small-pore size virus removal membrane at a filtration pressure of 0.30 kgf/cm 2 or lower, and
comprising, prior to the low-pressure filtration step (q), a step of adjusting the solution prior to filtration so that the solution prior to filtration in the step (q) has a pH (X) and a salt ionic strength (Y (mM)) that satisfy the following equations 1 and 5:
0 ≦Y ≦150 X −590 (Equation 1)
3.5≦X≦8.0 (Equation 5)
or the following equations 4 and 5:
Y=0 (Equation 4)
3.5≦X≦8.0, (Equation 5)
and
further comprising, prior to the low-pressure filtration step (q), a high-pressure filtration step (p) of filtering the virus-containing protein solution through the small-pore size virus removal membrane at a filtration pressure exceeding 0.30 kgf/cm 2 ,
wherein the low-pressure filtration step (q) is a post-wash step or a stop and start step, and
wherein pressurization is suspended during the filtration and then restarted in the stop and start step.
21. The method according to claim 1 , wherein a log reduction value (LRV) calculated according to the following equation 6 is 4 or higher:
LRV=log 10 ( C 0 / C F ) (Equation 6)
wherein C 0 represents the virus concentration of the virus-containing protein solution before the filtration step (a), and C F represents the virus concentration of the virus-free protein solution after the filtration, and LRV' calculated according to the following equation 7 is 4 or higher:
LRV=log 10 ( C 0 / C w ) (Equation 7)
wherein C 0 represents the virus concentration of the virus-containing protein solution before the filtration step (a), and C w represents the virus concentration of the filtrate of the buffer solution for washing after the filtration step (a).